Literature DB >> 8032632

Evoked noradrenaline release in the rabbit ear artery: enhancement by purines, attenuation by neuropeptide Y and lack of effect of calcitonin gene-related peptide.

K I Maynard1, G Burnstock.   

Abstract

1. Adenosine (30 microM) and its analogues 5'-N-ethylcarboxaminoadenosine (5 and 30 microM) and L-phenylisopropyladenosine (5 and 30 microM), potentiated the evoked but not spontaneous release of tritiated noradrenaline in the rabbit central ear artery. 2. Prejunctional inhibition of the evoked but not spontaneous release of tritiated noradrenaline by 100 nM neuropeptide Y is greater at 2 min than at 10 min after superfusion of the peptide. 3. Calcitonin gene-related peptide (2.63 to 263 nM) did not affect the evoked or spontaneous release of tritiated noradrenaline in this preparation. 4. These results are discussed in terms of prejunctional modulation of sympathetic transmission in the rabbit central ear artery.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8032632      PMCID: PMC1910278          DOI: 10.1111/j.1476-5381.1994.tb13040.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  32 in total

Review 1.  Regulation of noradrenaline release by presynaptic receptor systems.

Authors:  K Starke
Journal:  Rev Physiol Biochem Pharmacol       Date:  1977       Impact factor: 5.545

Review 2.  Adenosine as a neuromodulator.

Authors:  S H Snyder
Journal:  Annu Rev Neurosci       Date:  1985       Impact factor: 12.449

3.  ATP produces vasodilation via P1 purinoceptors and vasoconstriction via P2 purinoceptors in the isolated rabbit central ear artery.

Authors:  C Kennedy; G Burnstock
Journal:  Blood Vessels       Date:  1985

4.  Characterization of P1-purinoceptors on rat duodenum and urinary bladder.

Authors:  J Nicholls; S M Hourani; I Kitchen
Journal:  Br J Pharmacol       Date:  1992-03       Impact factor: 8.739

5.  Neuropeptide Y co-exists and co-operates with noradrenaline in perivascular nerve fibers.

Authors:  E Ekblad; L Edvinsson; C Wahlestedt; R Uddman; R Håkanson; F Sundler
Journal:  Regul Pept       Date:  1984-04

6.  Evidence that the P1-purinoceptor in the guinea-pig taenia coli is an A2-subtype.

Authors:  G Burnstock; J M Hills; C H Hoyle
Journal:  Br J Pharmacol       Date:  1984-03       Impact factor: 8.739

7.  Increased sensitivity of rabbit ear artery to noradrenaline following perivascular nerve stimulation may be a response to neuropeptide Y released as cotransmitter.

Authors:  W E Glover
Journal:  Clin Exp Pharmacol Physiol       Date:  1985 May-Jun       Impact factor: 2.557

8.  Electrical responses of smooth muscle cells of the rabbit ear artery to adenosine triphosphate.

Authors:  H Suzuki
Journal:  J Physiol       Date:  1985-02       Impact factor: 5.182

9.  Interaction of peptides present in perivascular nerves on the smooth muscle of cat cerebral arteries and on the stimulation-evoked efflux of 3H-noradrenaline.

Authors:  L Edvinsson; T Skärby
Journal:  J Auton Pharmacol       Date:  1984-09

10.  Calcitonin gene-related peptide is present in mammalian cerebrovascular nerve fibres and dilates pial and peripheral arteries.

Authors:  J Hanko; J E Hardebo; J Kåhrström; C Owman; F Sundler
Journal:  Neurosci Lett       Date:  1985-06-04       Impact factor: 3.046

View more
  3 in total

1.  Heterogeneity of prejunctional NPY receptor-mediated inhibition of cardiac neurotransmission.

Authors:  A P Serone; C E Wright; J A Angus
Journal:  Br J Pharmacol       Date:  1999-05       Impact factor: 8.739

2.  Contribution of adenosine to the depression of sympathetically evoked vasoconstriction induced by systemic hypoxia in the rat.

Authors:  Andrew M Coney; Janice M Marshall
Journal:  J Physiol       Date:  2003-04-17       Impact factor: 5.182

3.  Characterization of the non-adrenergic/non-cholinergic response to perivascular nerve stimulation in the double-perfused mesenteric bed of the mouse.

Authors:  E Legros; C R Tirapelli; E Carrier; I Brochu; A Fournier; P D'Orléans-Juste
Journal:  Br J Pharmacol       Date:  2007-10-01       Impact factor: 8.739

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.